ATAI | Investor Presentation Deck | 31 slides · page 12 of 31
The slide highlights that low doses (40 or 80 mg TID) of RL-007 show superior cognitive performance compared to higher doses and Pregabalin.
Pitch deck · traction · show_traction · dense density
Slide locked Sign in to view
Slide schematic 6/6
chart 2/2 paragraph 1/1 source-note 1/1 title 2/2
Components 6
bar-vertical bar-vertical paragraph source-note action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.